ZA934264B - Substituted (benzothiazolyl- and quinoxalyl-methoxy) phenyl-acetic acid derivatives - Google Patents

Substituted (benzothiazolyl- and quinoxalyl-methoxy) phenyl-acetic acid derivatives

Info

Publication number
ZA934264B
ZA934264B ZA934264A ZA934264A ZA934264B ZA 934264 B ZA934264 B ZA 934264B ZA 934264 A ZA934264 A ZA 934264A ZA 934264 A ZA934264 A ZA 934264A ZA 934264 B ZA934264 B ZA 934264B
Authority
ZA
South Africa
Prior art keywords
quinoxalyl
benzothiazolyl
methoxy
phenyl
substituted
Prior art date
Application number
ZA934264A
Other languages
English (en)
Inventor
Klaus-Helmut Mohrs
Siegfried Raddatz
Michael Matzke
Burkhard Fugmann
Romanis Fruchtmann
Armin Hatzelmann
Reiner Mueller-Peddinghaus
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA934264B publication Critical patent/ZA934264B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/42—Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ZA934264A 1992-06-17 1993-06-16 Substituted (benzothiazolyl- and quinoxalyl-methoxy) phenyl-acetic acid derivatives ZA934264B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4219765A DE4219765A1 (de) 1992-06-17 1992-06-17 Substituierte (Benzothiazolyl- und Chinoxalyl-methoxy)phenylessigsäurederivate

Publications (1)

Publication Number Publication Date
ZA934264B true ZA934264B (en) 1994-01-14

Family

ID=6461172

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA934264A ZA934264B (en) 1992-06-17 1993-06-16 Substituted (benzothiazolyl- and quinoxalyl-methoxy) phenyl-acetic acid derivatives

Country Status (14)

Country Link
EP (1) EP0574774A1 (cs)
JP (1) JPH0665214A (cs)
KR (1) KR940000436A (cs)
CN (1) CN1084166A (cs)
AU (1) AU3981793A (cs)
CA (1) CA2098366A1 (cs)
CZ (1) CZ109593A3 (cs)
DE (1) DE4219765A1 (cs)
FI (1) FI932743A (cs)
HU (1) HU9301754D0 (cs)
IL (1) IL106011A0 (cs)
NO (1) NO932031L (cs)
SK (1) SK62293A3 (cs)
ZA (1) ZA934264B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1238307B (it) * 1989-12-22 1993-07-12 Testata per motori alternativi endotermici munita di almeno una valvola comandata sia per aspirazione sia per scarico.
DE4443891A1 (de) * 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
DE19525028A1 (de) * 1995-07-10 1997-01-16 Bayer Ag Amide und Sulfonamide von heterocyclisch substituierten Benzylaminen
JP6557588B2 (ja) 2015-12-04 2019-08-07 株式会社日立ハイテクノロジーズ ドライエッチング方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4594425A (en) * 1984-02-09 1986-06-10 American Home Products Corporation Heterocyclic compounds as antiallergic agents
US4675405A (en) * 1984-09-21 1987-06-23 American Home Products Corporation Quinoline compounds as antiallergic and antithrombotic agents
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
JPS62142168A (ja) * 1985-10-16 1987-06-25 Mitsubishi Chem Ind Ltd チアゾ−ル誘導体及びそれを有効成分とするロイコトリエンきつ抗剤
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
IE66512B1 (en) * 1989-02-28 1996-01-10 Ici Plc Heterocyclic ethers as 5-lipoxygenase inhibitors
DE3927931A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate
PT95692A (pt) * 1989-10-27 1991-09-13 American Home Prod Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
DE4105551A1 (de) * 1991-02-22 1992-08-27 Bayer Ag 2-substituierte chinoline, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE4128681A1 (de) * 1991-08-29 1993-03-04 Bayer Ag Substituierte mandelsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE4129742A1 (de) * 1991-09-06 1993-03-11 Bayer Ag Heterocyclisch substituierte chinolylmethoxy-phenylacetamide

Also Published As

Publication number Publication date
IL106011A0 (en) 1993-10-20
HU9301754D0 (en) 1993-09-28
CN1084166A (zh) 1994-03-23
JPH0665214A (ja) 1994-03-08
FI932743A0 (fi) 1993-06-15
CA2098366A1 (en) 1993-12-18
CZ109593A3 (en) 1994-01-19
EP0574774A1 (de) 1993-12-22
NO932031D0 (no) 1993-06-03
NO932031L (no) 1993-12-20
KR940000436A (ko) 1994-01-17
FI932743A (fi) 1993-12-18
AU3981793A (en) 1993-12-23
SK62293A3 (en) 1994-02-02
DE4219765A1 (de) 1993-12-23

Similar Documents

Publication Publication Date Title
EP0520277A3 (en) 7-azaisoindolinyl-quinolone- and naphthyridoncarboxylic acid derivatives
AU3105493A (en) Quinolone- and naphthyridone-carboxylic acid derivatives
PH30227A (en) 7-Isoindolinyl-quinolone-carboxylic acid derivatives
IL92497A0 (en) Beta-amino-boronic acid derivatives
IL103538A0 (en) Quinoxaline-carboxylic and-phosphonic acid derivatives
HU9203123D0 (en) Substituted imidazolyl-propenic acid derivatives
ZA93190B (en) Benzofuranyl- and thiophenylmethylthio-alkanecarboxylic acid derivatives
AU646762B2 (en) Cyclic-substituted imidazolyl-propenoic acid derivatives
HU9203124D0 (en) Imidazolyl-propenic acid derivatives
AU2979892A (en) Thiazolyl-substituted quinolylmethoxphenylacetic acid derivatives
ZA934264B (en) Substituted (benzothiazolyl- and quinoxalyl-methoxy) phenyl-acetic acid derivatives
HU9302728D0 (en) Pyridazinone-acetic acid derivatives
EP0421752A3 (en) Substituted acrylamido-penicillanic acid derivatives
ZA931367B (en) Sulphonylbenzyl-substituted imidazolylpropenoic acid derivatives
AP9200396A0 (en) Propenoic acid derivatives
ZA93125B (en) Quinolone- and naphthyridone-carboxylic acid derivatives
ZW13589A1 (en) Panicillanic acid derivatives
ZA903999B (en) Mevinic acid derivatives
IL98802A0 (en) Cyclopropylacetic acid derivatives
ZA922831B (en) Novel thienyl-nonatetraenoic acid derivatives
ZA924932B (en) 4-amino-3-hydroxycarboxylic acid derivatives
ZA924515B (en) 7-isoindolinyl-quinolone-and naphthyridonecarboxylic acid derivatives
ZA922022B (en) N-acyl-alpha-amino acid derivatives
IE883729L (en) Mercapto-acylamino acid derivatives
IE881969L (en) Piperidinylcyclopentylheptenoic acid derivatives